Morphosys AG O.N.(MOR) News

Date	Title
Apr 12	Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Dec 11	MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study